Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study

Autor: Michielsens, CAJ, Bolhuis, TE, van Gaalen, FA, van den Hoogen, FHJ, Verhoef, LM, Broeder, N den, Broeder, AA den

In axial spondyloarthritis (axSpA), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) are recommended for use in treat-to-target (T2T) strategies. However, BASDAI disease states

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::710ca3d617bc79f1b9959de0ac8ad40a

Dose reduction of biologics in patients with plaque psoriasis: a review.

Autor: van Riel CAM; Radboud University Medical Centre, Nijmegen, Netherlands.; Department of Dermatology, Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands., Michielsens CAJ; Radboud University Medical Centre, Nijmegen, Netherlands.; Department of Dermatology, Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands., van Muijen ME; Maastricht University Medical Centre, Maastricht, Limburg, Netherlands.; Department of Dermatology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands, Netherlands., van der Schoot LS; Radboud University Medical Centre, Nijmegen, Netherlands.; Department of Dermatology, Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands., van den Reek JMPA; Radboud University Medical Centre, Nijmegen, Netherlands.; Department of Dermatology, Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands., de Jong EMGJ; Radboud University Medical Centre, Nijmegen, Netherlands.; Department of Dermatology, Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands.; Radboud University, Nijmegen, Gelderland, Netherlands.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2024 Mar 28; Vol. 15, pp. 1369805. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2024).

Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study.

Autor: Michielsens CAJ; Department of Rheumatology, Sint Maartenskliniek Nijmegen.; Department of Rheumatic Diseases, Radboud Institute for Health Sciences, Radboudumc Nijmegen, the Netherlands., den Broeder N; Department of Rheumatology, Sint Maartenskliniek Nijmegen., Mulder MLM; Department of Rheumatology, Sint Maartenskliniek Nijmegen.; Department of Rheumatic Diseases, Radboud Institute for Health Sciences, Radboudumc Nijmegen, the Netherlands., van den Hoogen FHJ; Department of Rheumatology, Sint Maartenskliniek Nijmegen.; Department of Rheumatic Diseases, Radboud Institute for Health Sciences, Radboudumc Nijmegen, the Netherlands., Verhoef LM; Department of Rheumatology, Sint Maartenskliniek Nijmegen., den Broeder AA; Department of Rheumatology, Sint Maartenskliniek Nijmegen.; Department of Rheumatic Diseases, Radboud Institute for Health Sciences, Radboudumc Nijmegen, the Netherlands.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2022 May 30; Vol. 61 (6), pp. 2307-2315.

Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial.

Autor: Michielsens CAJ; Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6574 NA, Nijmegen, The Netherlands. c.michielsens@maartenskliniek.nl.; Department of Rheumatic Diseases, Radboud Institute of Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. c.michielsens@maartenskliniek.nl., Boers N; Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6574 NA, Nijmegen, The Netherlands., den Broeder N; Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6574 NA, Nijmegen, The Netherlands., Wenink MH; Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6574 NA, Nijmegen, The Netherlands., van der Maas A; Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6574 NA, Nijmegen, The Netherlands., Mahler EAM; Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6574 NA, Nijmegen, The Netherlands., Mulder MLM; Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6574 NA, Nijmegen, The Netherlands.; Department of Rheumatic Diseases, Radboud Institute of Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands., van der Heijde D; Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands., van den Hoogen FHJ; Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6574 NA, Nijmegen, The Netherlands.; Department of Rheumatic Diseases, Radboud Institute of Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands., Verhoef LM; Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6574 NA, Nijmegen, The Netherlands., den Broeder AA; Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6574 NA, Nijmegen, The Netherlands.; Department of Rheumatic Diseases, Radboud Institute of Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.

Publikováno v: Trials [Trials] 2020 Jan 15; Vol. 21 (1), pp. 90. Date of Electronic Publication: 2020 Jan 15.

Impact of High Age and Comorbidity on Management Decisions and Adherence to Guidelines in Patients with Keratinocyte Skin Cancer.

Autor: Lubeek SFK; Department of Dermatology, Radboud university medical center, PO Box 9101, 6500 HB Nijmegen, The Netherlands. satish.lubeek@radboudumc.nl., Michielsens CAJ, Borgonjen RJ, Bronkhorst EM, van de Kerkhof PCM, Gerritsen MP

Publikováno v: Acta dermato-venereologica [Acta Derm Venereol] 2017 Jul 06; Vol. 97 (7), pp. 825-829.